Related references
Note: Only part of the references are listed.Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer
Katherine E. Reeder-Hayes et al.
CANCER (2021)
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
Olivia Pagani et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review
Shoshana M. Rosenberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
S. Paluch-Shimon et al.
ANNALS OF ONCOLOGY (2020)
Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk
Barbara Pistilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis
Shibin Cai et al.
FRONTIERS IN ONCOLOGY (2020)
Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early Breast Cancer: A Multicenter Cohort Study
Arlindo R. Ferreira et al.
CLINICAL BREAST CANCER (2019)
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial
Francesco Perrone et al.
EUROPEAN JOURNAL OF CANCER (2019)
Incidence and Survival Among Young Women With Stage I-III Breast Cancer: SEER 2000-2015
Alexandra Thomas et al.
JNCI CANCER SPECTRUM (2019)
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
P. A. Francis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials
Poornima Saha et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial
Karin Ribi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status
Ju-Hyun Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Impact of Fertility Concerns on Tamoxifen Initiation and Persistence
Natalia C. Llarena et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
Prudence A. Francis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Impact of Fertility Concerns on Tamoxifen Initiation and Persistence
Natalia C. Llarena et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
M. Gnant et al.
ANNALS OF ONCOLOGY (2015)
Why have breast cancer mortality rates declined?
Steven A. Narod et al.
JOURNAL OF CANCER POLICY (2015)
Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor-Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group
Amye J. Tevaarwerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
Olivia Pagani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
Sandra M. Swain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
AH Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
